Logotype for National Healthcare Properties Inc

National Healthcare Properties (NHP) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for National Healthcare Properties Inc

Q2 2026 earnings summary

6 Aug, 2026

Executive summary

  • Completed a successful IPO in April 2026, raising $531.3 million and issuing 44.3 million shares, with proceeds used to repay debt and fund acquisitions.

  • Achieved substantial execution on strategic objectives, including SHOP portfolio growth, capital concentration in senior housing, and balance sheet strengthening.

  • Closed or placed under contract approximately $400 million of senior housing since Q2 start, with highly accretive yields and 19 acquisitions completed.

  • Advanced transition to a full SHOP portfolio, with significant divestitures of outpatient medical facilities (OMF) and non-core assets.

  • Strengthened governance with new board appointments, including Albert M. Campbell, and ongoing refreshment.

Financial highlights

  • Second quarter normalized FFO was $10.9 million, or $0.18 per share; Nareit FFO was $0.19 per share; net loss attributable to common stockholders was $(0.13) per share.

  • SHOP segment same-store cash NOI grew 20.1% year-over-year, driven by occupancy, rate, and margin improvements; OMF segment same-store cash NOI declined 0.4%.

  • Same-store average occupancy reached 84.1%, up 140 basis points from Q2 2025.

  • Same-store RevPOR increased 5.9% year-over-year to $6,390.

  • Consolidated NOI increased to $33.4 million from $31.2 million year-over-year.

Outlook and guidance

  • Increased SHOP same-store cash NOI growth guidance to 15%-18% for the year, or $51.6M-$52.9M.

  • OMF same-store cash NOI growth guidance unchanged at 2.5%-3.5%, or $81.2M-$82M.

  • Acquisition guidance for 2026 remains $375M-$425M; disposition guidance increased to $570M.

  • G&A and equity compensation guidance raised by $1M each due to board refreshment; full-year G&A now $27-$28M, equity-based compensation $6-$7M.

  • Recurring CapEx guidance unchanged at $22M-$25M, with spending weighted to the back half of the year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more